Ali Khademhosseini is the CEO and Director of Terasaki Institute for Biomedical Innovation, a research organization focused on enabling translational science and academic entrepreneurship. Ali is also the Founder and CEO of Omeat. Previously, Ali was a Co-Founder and Board member of Obsidio, Inc., a company that developed FDA cleared embolic material and was later sold to Boston Scientific. With a background in bioengineering and biomedical engineering, Ali has held various prestigious academic positions at institutions such as Harvard University, University of California, Los Angeles, and Massachusetts Institute of Technology.
Sign up to view 2 direct reports
Get started
This person is not in any teams